Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Daxor Corp (NYSE MKT LLC:DXR)

8.41
Delayed Data
As of Jan 10
 0.00 / 0.00%
Today’s Change
7.00
Today|||52-Week Range
9.80
+2.03%
Year-to-Date
No recent news for Daxor Corp.

Today’s Trading

Previous close8.41
Today’s openn.a.
Day’s range-- - --
Volume0
Average volume (3 months)1,675
Market cap$32.2M
Dividend yield0.36%
Data as of 01/10/2017

Growth & Valuation

Earnings growth (last year)-870.21%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales4.90
Price/Book2.25

Competitors

 Today’s
change
Today’s
% change
CYTXCytori Therapeutics ...+0.04+2.60%
ATECAlphatec Holdings In...+0.05+1.43%
ETRMEnteroMedics Inc-0.30-2.14%
MGCDMGC Diagnostics Corp+0.10+1.29%
Data as of 4:00pm ET, 01/13/2017

Financials

Last reporting dateNovember 11, 2010
EPS forecast (this quarter)$0.35
Annual revenue (last year)$5.9M
Annual profit (last year)-$9.1M
Net profit margin-154.12%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman &
Chief Scientific Officer
Joseph Feldschuh
President, Chief Executive Officer &
Director
Michael Feldschuh
Corporate headquarters
New York, New York

Forecasts

Chart unavailable

Search for Jobs